OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
STAF55

Stallion India Fluorochemicals Ltd

Commodity ChemicalsVerified

Stallion India Fluorochemicals Ltd maintains a strong liquidity position, with a current ratio of 9.45, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt score is high, supported by INR 589.4 million in cash and equivalents, which represents 18.3% of total assets. This liquidity provides a buffer against short-term obligations and supports operational flexibility. Profitability metrics show the company is performing well relative to industry norms. Return on equity (ROE) of 10.75% and return on assets (ROA) of 9.69% are both above the median for the Commodity Chemicals industry, indicating efficient use of equity and assets to generate returns. Operating income of INR 465.5 million and net income of INR 323.3 million reflect strong cost control and pricing power in its core markets. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The absence of segment or geographic breakdown in the financial snapshot suggests a need for further transparency in reporting. Growth trajectory appears stable, with no significant revenue acceleration or contraction in the most recent period. The company's capital expenditure of INR 46.5 million is modest, suggesting a conservative approach to reinvestment. Free cash flow of INR 288.4 million indicates the company is generating sufficient cash to support operations and potentially fund future growth. Risk assessment indicates low liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio of 0.01 is well below the industry median, suggesting a conservative capital structure. No dilution sources were identified in the risk assessment, and the dilution_near_term_probability is low. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's operating cash flow is negative at INR 134.3 million, which may be due to working capital requirements or capital investment timing. However, this is offset by strong free cash flow generation, suggesting the company is managing its cash effectively.

30-day price · STAF+38.95 (+28.4%)
Low$129.81High$180.00Close$175.87As of25 May, 00:00 UTC
Profile
CompanyStallion India Fluorochemicals Ltd
TickerSTAF.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Stallion India Fluorochemicals Ltd is a chemical manufacturing company that produces and sells fluorochemicals and related products, primarily serving the pharmaceutical and agrochemical industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Stallion India Fluorochemicals Ltd maintains a strong liquidity position, with a current ratio of 9.45, indicating that it holds significantly more current assets than current liabilities. The company's liquidity_fpt score is high, supported by INR 589.4 million in cash and equivalents, which represents 18.3% of total assets. This liquidity provides a buffer against short-term obligations and supports operational flexibility. Profitability metrics show the company is performing well relative to industry norms. Return on equity (ROE) of 10.75% and return on assets (ROA) of 9.69% are both above the median for the Commodity Chemicals industry, indicating efficient use of equity and assets to generate returns. Operating income of INR 465.5 million and net income of INR 323.3 million reflect strong cost control and pricing power in its core markets. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The absence of segment or geographic breakdown in the financial snapshot suggests a need for further transparency in reporting. Growth trajectory appears stable, with no significant revenue acceleration or contraction in the most recent period. The company's capital expenditure of INR 46.5 million is modest, suggesting a conservative approach to reinvestment. Free cash flow of INR 288.4 million indicates the company is generating sufficient cash to support operations and potentially fund future growth. Risk assessment indicates low liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio of 0.01 is well below the industry median, suggesting a conservative capital structure. No dilution sources were identified in the risk assessment, and the dilution_near_term_probability is low. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's operating cash flow is negative at INR 134.3 million, which may be due to working capital requirements or capital investment timing. However, this is offset by strong free cash flow generation, suggesting the company is managing its cash effectively.
Key takeaways
  • Stallion India Fluorochemicals Ltd has a strong liquidity position with a current ratio of 9.45 and INR 589.4 million in cash and equivalents.
  • The company's ROE of 10.75% and ROA of 9.69% are above industry medians, indicating strong profitability.
  • Revenue is concentrated in a single segment, with no geographic diversification disclosed, increasing exposure to regional risks.
  • Free cash flow of INR 288.4 million supports operational flexibility and potential reinvestment.
  • Low liquidity and dilution risk, with no immediate filing-based flags and a debt-to-equity ratio of 0.01.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$3.77B
Gross profit$901.8M
Operating income$465.5M
Net income$323.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$134.3M
CapEx-$46.5M
Free cash flow$288.4M
Total assets$3.34B
Total liabilities$328.2M
Total equity$3.01B
Cash & equivalents$589.4M
Long-term debt$24.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.01B
Net cash$565.0M
Current ratio9.4
Debt/Equity0.0
ROA9.7%
ROE10.8%
Cash conversion-42.0%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricSTAFActivity
Op margin12.3%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin8.6%4.1% medp25 0.1% · p75 8.8%above median
Gross margin23.9%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-1.2%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity1.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-24 20:15 UTC#7b596648
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 13:58 UTCJob: 83f53b2c